共 114 条
- [1] Menu P(2011)The NLRP3 inflammasome in health and disease: the good, the bad and the ugly Clin. Exp. Immunol. 166 1-15
- [2] Vince JE(2012)Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases Nat. Rev. Drug Discov. 11 633-652
- [3] Dinarello CA(2019)Inflammasomes in neuroinflammatory and neurodegenerative diseases EMBO Mol. Med. 11 e10248-1710
- [4] Simon A(2016)Inhibiting the inflammasome: a chemical perspective J. Med. Chem. 59 1691-832
- [5] van der Meer JW(2010)The inflammasomes Cell 140 821-420
- [6] Voet S(2016)Inflammasomes: mechanism of assembly, regulation and signalling Nat. Rev. Immunol. 16 407-840
- [7] Srinivasan S(2018)Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity J. Exp. Med. 215 827-399
- [8] Lamkanfi M(2019)Stressing out the Mitochondria: mechanistic insights into NLRP3 inflammasome activation J. Leukoc. Biol. 105 377-665
- [9] van Loo G(2015)Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death Nature 526 660-671
- [10] Baldwin AG(2015)Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling Nature 526 666-1298